GlassScriptPhysician profile
Christopher O Austin
NPI 1508178567
$11,984.62
in general payments reported to CMS, 2019-2025
40 companies · $1,813 in 2025
The $1,813 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,864 · 2020: $234 · 2021: $1,243 · 2022: $1,685 · 2023: $1,203 · 2024: $1,943 · 2025: $1,813.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,272 · Travel and Lodging: $687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,271.66 |
| Travel and Lodging | $687.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $3,413.23 | 2019-2020 | |
| Medtronic, INC. | $1,581.37 | 2021-2025 | Cobalt Dr Mri Surescan, Affera Mapping System, Capsure Sense |
| Biosense Webster, INC. | $1,060.63 | 2019-2025 | Qdot Micro Catheter, Carto 3, Nuvision Ice Catheter |
| Boston Scientific Corporation | $1,029.98 | 2019-2025 | Watchman Flx, Farapulse, Resonate El Icd Vr |
| Abbott Laboratories | $920.23 | 2021-2025 | Aveir, Triclip, Ensite Precision |
| Medical Device Business Services, INC. | $588.58 | 2024 | Carto 3 |
| Janssen Pharmaceuticals, INC | $470.48 | 2019-2023 | Xarelto |
| Cvrx, INC. | $338.72 | 2021-2024 | Barostim Neo System |
| Biotronik INC. | $329.85 | 2019-2022 | |
| Acutus Medical, INC. | $270.48 | 2022-2023 | |
| Atricure, INC. | $239.80 | 2021-2022 | |
| Pfizer INC. | $175.93 | 2020-2025 | |
| Elutia, INC. | $155.84 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $146.24 | 2020-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $140.57 | 2019-2024 | Lifevest |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $107.32 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Novo Nordisk INC | $101.36 | 2020-2025 | Wegovy |
| Philips North America LLC | $77.42 | 2024-2025 | (Ck4) Mcot, Extended Holter |
| Cardiofocus, INC. | $74.19 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $73.32 | 2019-2024 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $66.50 | 2019-2024 | Wainua |
| Catheter Precision INC. | $55.55 | 2025 | |
| Scpharmaceuticals INC. | $52.76 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.55 | 2019-2025 | Jardiance |
| Kiniksa Pharmaceuticals International, Plc | $46.40 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $44.43 | 2022-2025 | Nexletol |
| Actelion Pharmaceuticals US, INC. | $40.40 | 2020-2022 | |
| Impulse Dynamics (USA) INC. | $40.13 | 2023 | Optimizer |
| Cordis US Corp. | $38.90 | 2025 | Mynx Control Venous |
| Novartis Pharmaceuticals Corporation | $36.91 | 2022-2025 | |
| Alnylam Pharmaceuticals INC. | $36.46 | 2021-2025 | Amvuttra |
| Stryker Corporation | $28.40 | 2022 | |
| Amgen INC. | $25.86 | 2020-2023 | Repatha |
| Tactile Systems Technology INC | $24.14 | 2025 | Nimbl, Flexitouch Plus |
| Convatec INC. | $20.20 | 2025 | |
| Lilly USA, LLC | $20.17 | 2024 | Zepbound |
| Merck Sharp & Dohme LLC | $19.63 | 2025 | Verquvo |
| Kestra Medical Technology Services, INC. | $15.87 | 2025 | Assure Wcd |
| Innovation Technologies INC | $15.04 | 2025 | Irrisept |
| Kiniksa Pharmaceuticals, LTD. | $12.78 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Austin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.